Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

COVID-19 vaccine makers start work on Omicron-tailored shots

11/29/2021 | 09:32am EST
FILE PHOTO: Test tubes are seen in front of a displayed Moderna logo in this illustration

(Reuters) -BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said on Monday.

The variant's emergence has triggered a strong global response as countries worried that it could spread fast even in vaccinated populations impose travel curbs and other restrictions.

BioNTech SE said it had started work on a vaccine tailored to Omicron, along with partner Pfizer.

Meanwhile, Moderna Inc said it could take months to begin shipping such a vaccine, Chief Executive Officer Stéphane Bancel told CNBC.

Bancel said the effectiveness of existing COVID-19 vaccines against the variant was currently not known, adding there should be more clarity in about two weeks.

Johnson & Johnson is also evaluating the effectiveness of its COVID-19 vaccine against Omicron, while also pursuing a vaccine specific to the variant.

"We have begun work to design and develop a new vaccine against Omicron and will rapidly progress it into clinical studies if needed," said Mathai Mammen, global head of research for J&J's pharmaceuticals unit.

A top South African infectious disease expert said Omicron appears to be more transmissible than previous variants, including to people with immunity from vaccination or prior infection.

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE 2.69% 160.7 Delayed Quote.-37.66%
MODERNA, INC. 1.59% 154.96 Delayed Quote.-38.99%
PFIZER, INC. 0.89% 53.01 Delayed Quote.-10.23%
Latest news "Economy & Forex"
03:13aLondon Shares to Fall After Downbeat Asia, US Trading
03:11aUniCredit agrees 1,200 voluntary staff exits with Italian banking unions
03:10aRenault-nissan-mitsubishi motors say alliance will spend $23 bil…
03:10aRenault-nissan-mitsubishi motors say alliance plans to have 35 e…
03:10aRenault-nissan-mitsubishi motors say alliance will increase comm…
03:10aRenault-nissan-mitsubishi motors say their alliance to have 90 m…
03:08aClose Putin ally urges diplomatic path with U.S. in Ukraine crisis
03:08aMARKETMIND : More than four
03:08aBritish holidays group Saga eyes return to profit in fiscal 2022/23
03:07aJordan's army says 27 drug smugglers killed at border with Syria
Latest news "Economy & Forex"